107 related articles for article (PubMed ID: 9462649)
1. Involvement of intrasinusoidal hemostasis in the development of concanavalin A-induced hepatic injury in mice.
Miyazawa Y; Tsutsui H; Mizuhara H; Fujiwara H; Kaneda K
Hepatology; 1998 Feb; 27(2):497-506. PubMed ID: 9462649
[TBL] [Abstract][Full Text] [Related]
2. Strain difference in the induction of T-cell activation-associated, interferon gamma-dependent hepatic injury in mice.
Mizuhara H; Kuno M; Seki N; Yu WG; Yamaoka M; Yamashita M; Ogawa T; Kaneda K; Fujii T; Senoh H; Fujiwara H
Hepatology; 1998 Feb; 27(2):513-9. PubMed ID: 9462651
[TBL] [Abstract][Full Text] [Related]
3. Critical involvement of interferon gamma in the pathogenesis of T-cell activation-associated hepatitis and regulatory mechanisms of interleukin-6 for the manifestations of hepatitis.
Mizuhara H; Uno M; Seki N; Yamashita M; Yamaoka M; Ogawa T; Kaneda K; Fujii T; Senoh H; Fujiwara H
Hepatology; 1996 Jun; 23(6):1608-15. PubMed ID: 8675184
[TBL] [Abstract][Full Text] [Related]
4. Ursodeoxycholic acid protects concanavalin A-induced mouse liver injury through inhibition of intrahepatic tumor necrosis factor-alpha and macrophage inflammatory protein-2 production.
Ishizaki K; Iwaki T; Kinoshita S; Koyama M; Fukunari A; Tanaka H; Tsurufuji M; Sakata K; Maeda Y; Imada T; Chiba K
Eur J Pharmacol; 2008 Jan; 578(1):57-64. PubMed ID: 17888421
[TBL] [Abstract][Full Text] [Related]
5. Interferon gamma plays a critical role in T cell-dependent liver injury in mice initiated by concanavalin A.
Küsters S; Gantner F; Künstle G; Tiegs G
Gastroenterology; 1996 Aug; 111(2):462-71. PubMed ID: 8690213
[TBL] [Abstract][Full Text] [Related]
6. Immunopathogenesis of hepatic fibrosis in chronic liver injury induced by repeatedly administered concanavalin A.
Kimura K; Ando K; Ohnishi H; Ishikawa T; Kakumu S; Takemura M; Muto Y; Moriwaki H
Int Immunol; 1999 Sep; 11(9):1491-500. PubMed ID: 10464170
[TBL] [Abstract][Full Text] [Related]
7. Interferon-gamma-mediated tissue factor expression contributes to T-cell-mediated hepatitis through induction of hypercoagulation in mice.
Kato J; Okamoto T; Motoyama H; Uchiyama R; Kirchhofer D; Van Rooijen N; Enomoto H; Nishiguchi S; Kawada N; Fujimoto J; Tsutsui H
Hepatology; 2013 Jan; 57(1):362-72. PubMed ID: 22936459
[TBL] [Abstract][Full Text] [Related]
8. Concanavalin-A-induced liver injury is severely impaired in mice deficient in P-selectin.
Massaguer A; Perez-Del-Pulgar S; Engel P; Serratosa J; Bosch J; Pizcueta P
J Leukoc Biol; 2002 Aug; 72(2):262-70. PubMed ID: 12149416
[TBL] [Abstract][Full Text] [Related]
9. Rapamycin prevents concanavalin A-induced liver injury by inhibiting lymphocyte activation.
Zhang Y; Xiao X; Li X; Wei H
J Gastroenterol Hepatol; 2009 Aug; 24(8):1457-62. PubMed ID: 19496899
[TBL] [Abstract][Full Text] [Related]
10. A selective adenosine A2A receptor agonist, ATL-146e, prevents concanavalin A-induced acute liver injury in mice.
Odashima M; Otaka M; Jin M; Horikawa Y; Matsuhashi T; Ohba R; Linden J; Watanabe S
Biochem Biophys Res Commun; 2006 Sep; 347(4):949-54. PubMed ID: 16859640
[TBL] [Abstract][Full Text] [Related]
11. Concanavalin A induces perforin-mediated but not Fas-mediated hepatic injury.
Watanabe Y; Morita M; Akaike T
Hepatology; 1996 Sep; 24(3):702-10. PubMed ID: 8781346
[TBL] [Abstract][Full Text] [Related]
12. Experimental hepatitis and role of cytokines.
Tiegs G
Acta Gastroenterol Belg; 1997; 60(2):176-9. PubMed ID: 9260332
[TBL] [Abstract][Full Text] [Related]
13. T cell activation-associated hepatic injury: mediation by tumor necrosis factors and protection by interleukin 6.
Mizuhara H; O'Neill E; Seki N; Ogawa T; Kusunoki C; Otsuka K; Satoh S; Niwa M; Senoh H; Fujiwara H
J Exp Med; 1994 May; 179(5):1529-37. PubMed ID: 8163936
[TBL] [Abstract][Full Text] [Related]
14. Pre-activation of T lymphocytes by low dose of concanavalin A aggravates toll-like receptor-3 ligand-induced NK cell-mediated liver injury.
Wang J; Sun R; Wei H; Dong Z; Tian Z
Int Immunopharmacol; 2006 May; 6(5):800-7. PubMed ID: 16546711
[TBL] [Abstract][Full Text] [Related]
15. Anti-tumor necrosis factor modulates anti-CD3-triggered T cell cytokine gene expression in vivo.
Ferran C; Dautry F; Mérite S; Sheehan K; Schreiber R; Grau G; Bach JF; Chatenoud L
J Clin Invest; 1994 May; 93(5):2189-96. PubMed ID: 8182150
[TBL] [Abstract][Full Text] [Related]
16. Glycogen synthase kinase-3 facilitates con a-induced IFN-γ-- mediated immune hepatic injury.
Tsai CC; Huang WC; Chen CL; Hsieh CY; Lin YS; Chen SH; Yang KC; Lin CF
J Immunol; 2011 Oct; 187(7):3867-77. PubMed ID: 21873526
[TBL] [Abstract][Full Text] [Related]
17. A T cell-dependent experimental liver injury in mice inducible by concanavalin A.
Tiegs G; Hentschel J; Wendel A
J Clin Invest; 1992 Jul; 90(1):196-203. PubMed ID: 1634608
[TBL] [Abstract][Full Text] [Related]
18. 1-Methylnicotinamide protects against liver injury induced by concanavalin A via a prostacyclin-dependent mechanism: A possible involvement of IL-4 and TNF-α.
Jakubowski A; Sternak M; Jablonski K; Ciszek-Lenda M; Marcinkiewicz J; Chlopicki S
Int Immunopharmacol; 2016 Feb; 31():98-104. PubMed ID: 26709075
[TBL] [Abstract][Full Text] [Related]
19. Possible changes in expression of chemotaxin LECT2 mRNA in mouse liver after concanavalin A-induced hepatic injury.
Segawa Y; Itokazu Y; Inoue N; Saito T; Suzuki K
Biol Pharm Bull; 2001 Apr; 24(4):425-8. PubMed ID: 11305608
[TBL] [Abstract][Full Text] [Related]
20. Requirement of IL-4 and liver NK1+ T cells for concanavalin A-induced hepatic injury in mice.
Toyabe S; Seki S; Iiai T; Takeda K; Shirai K; Watanabe H; Hiraide H; Uchiyama M; Abo T
J Immunol; 1997 Aug; 159(3):1537-42. PubMed ID: 9233653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
